Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Pharmacokinetic Study of OP-2024 in Healthy Male Volunteers
jRCT2071210039Phase 1Completed
- Sponsor
- Ohara Pharmaceutical Co., Ltd.
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of XI Ning in Parkinson's disease (PD) (2 arms), sponsored by Ohara Pharmaceutical Co., Ltd. Primary endpoint: Pharmacokinetics of OP-2024. Started Jul 2021; status: completed.
02
Drugs
XI Ning
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2071210039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210039.